These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14614048)

  • 1. Methylation profiling of benign and malignant breast lesions and its application to cytopathology.
    Pu RT; Laitala LE; Alli PM; Fackler MJ; Sukumar S; Clark DP
    Mod Pathol; 2003 Nov; 16(11):1095-101. PubMed ID: 14614048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of tumor markers including carcinoembryonic antigen, APC, and cyclin D2 in fine-needle aspiration fluid of breast.
    Lee A; Kim Y; Han K; Kang CS; Jeon HM; Shim SI
    Arch Pathol Lab Med; 2004 Nov; 128(11):1251-6. PubMed ID: 15508191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.
    Lewis CM; Cler LR; Bu DW; Zöchbauer-Müller S; Milchgrub S; Naftalis EZ; Leitch AM; Minna JD; Euhus DM
    Clin Cancer Res; 2005 Jan; 11(1):166-72. PubMed ID: 15671542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative hypermethylation of a small panel of genes augments the diagnostic accuracy in fine-needle aspirate washings of breast lesions.
    Jeronimo C; Monteiro P; Henrique R; Dinis-Ribeiro M; Costa I; Costa VL; Filipe L; Carvalho AL; Hoque MO; Pais I; Leal C; Teixeira MR; Sidransky D
    Breast Cancer Res Treat; 2008 May; 109(1):27-34. PubMed ID: 17549626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of gene promoter hypermethylation in fine needle washings from breast lesions.
    Jerónimo C; Costa I; Martins MC; Monteiro P; Lisboa S; Palmeira C; Henrique R; Teixeira MR; Lopes C
    Clin Cancer Res; 2003 Aug; 9(9):3413-7. PubMed ID: 12960130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
    Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of estrogen receptor beta promoter correlates with loss of ER-beta expression in mammary carcinoma and is an early indication marker in premalignant lesions.
    Rody A; Holtrich U; Solbach C; Kourtis K; von Minckwitz G; Engels K; Kissler S; Gätje R; Karn T; Kaufmann M
    Endocr Relat Cancer; 2005 Dec; 12(4):903-16. PubMed ID: 16322330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
    Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
    Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilization of microdissection and the polymerase chain reaction for the diagnosis of adrenal cortical carcinoma in fine-needle aspiration cytology.
    Abati A; Sanjuan X; Wilder A; Linehan WM; Hewitt SM; Merino MJ
    Cancer; 1999 Aug; 87(4):231-7. PubMed ID: 10455212
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions.
    Martins AT; Monteiro P; Ramalho-Carvalho J; Costa VL; Dinis-Ribeiro M; Leal C; Henrique R; Jerónimo C
    Breast Cancer Res Treat; 2011 Aug; 129(1):1-9. PubMed ID: 20842524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors.
    Parrella P; Poeta ML; Gallo AP; Prencipe M; Scintu M; Apicella A; Rossiello R; Liguoro G; Seripa D; Gravina C; Rabitti C; Rinaldi M; Nicol T; Tommasi S; Paradiso A; Schittulli F; Altomare V; Fazio VM
    Clin Cancer Res; 2004 Aug; 10(16):5349-54. PubMed ID: 15328171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation profile of ovarian epithelial neoplasms.
    Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
    Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA methylation in benign breast epithelium in relation to age and breast cancer risk.
    Euhus DM; Bu D; Milchgrub S; Xie XJ; Bian A; Leitch AM; Lewis CM
    Cancer Epidemiol Biomarkers Prev; 2008 May; 17(5):1051-9. PubMed ID: 18483325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of p57KIP2 gene in lung and breast cancers and malignant mesotheliomas.
    Kobatake T; Yano M; Toyooka S; Tsukuda K; Dote H; Kikuchi T; Toyota M; Ouchida M; Aoe M; Date H; Pass HI; Doihara H; Shimizu N
    Oncol Rep; 2004 Nov; 12(5):1087-92. PubMed ID: 15492797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation in histologically distinct classes of breast cancer.
    Bae YK; Brown A; Garrett E; Bornman D; Fackler MJ; Sukumar S; Herman JG; Gabrielson E
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):5998-6005. PubMed ID: 15447983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Detection and significance of APC gene promoter hypermethylation in serum of breast cancer patients].
    Zhang JJ; Ouyang T; Wan WH; Xu GW; Deng GR
    Ai Zheng; 2007 Jan; 26(1):44-7. PubMed ID: 17222366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative methylation profiling in tumor and matched morphologically normal tissues from breast cancer patients.
    Van der Auwera I; Bovie C; Svensson C; Trinh XB; Limame R; van Dam P; van Laere SJ; van Marck EA; Dirix LY; Vermeulen PB
    BMC Cancer; 2010 Mar; 10():97. PubMed ID: 20226036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mapping geographic zones of cancer risk with epigenetic biomarkers in normal breast tissue.
    Yan PS; Venkataramu C; Ibrahim A; Liu JC; Shen RZ; Diaz NM; Centeno B; Weber F; Leu YW; Shapiro CL; Eng C; Yeatman TJ; Huang TH
    Clin Cancer Res; 2006 Nov; 12(22):6626-36. PubMed ID: 17121881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of CpG island methylation in progressive breast lesions from normal to invasive carcinoma.
    Pasquali L; Bedeir A; Ringquist S; Styche A; Bhargava R; Trucco G
    Cancer Lett; 2007 Nov; 257(1):136-44. PubMed ID: 17706863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.